Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Block

Showing results (371-380 of 540) with videos related to

Pageof 54
Sort By:
Vaccine|September 10, 2019
MenACWY-CRM conjugate vaccine booster dose given 4-6 years after priming: Results from a phase IIIb, multicenter, open label study in adolescents and adultsMary Tipton, Wendy Daly, Shelly Senders, et al.
Journal of Neuroinflammation|May 7, 2013
Microglial activation decreases retention of the protease inhibitor saquinavir: implications for HIV treatmentShannon Dallas, Michelle L Block, Deborah M Thompson, et al.
Journal of Allied Health|October 12, 2000
Facilitating factors for, barriers to, and outcomes of interdisciplinary education projects in the health sciencesI Ruebling, M A Lavin, R Banks, et al.
Neuroendocrinology|March 2, 2012
Inhibitory effects of GHRH antagonists on human GH-secreting adenoma tissueLuca Szalontay, Ronald J Benveniste, Andrew V Schally, et al.
The Journal of Biological Chemistry|October 28, 2003
NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microgliaLiya Qin, Yuxin Liu, Tongguang Wang, et al.
Investigative Urology|July 1, 1981
Flow cytometric monitoring of R 3327 rat prostate carcinomaJ M Collins, C B Bagwell, N L Block, et al.
The Prostate|October 15, 2010
LHRH antagonist Cetrorelix reduces prostate size and gene expression of proinflammatory cytokines and growth factors in a rat model of benign prostatic hyperplasiaFerenc G Rick, Andrew V Schally, Norman L Block, et al.
The Prostate|September 23, 2010
Receptors for luteinizing hormone-releasing hormone (LHRH) in benign prostatic hyperplasia (BPH) as potential molecular targets for therapy with LHRH antagonist cetrorelixBernadett Rozsa, Mehrdad Nadji, Andrew V Schally, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 13, 2010
Acceleration of wound healing by growth hormone-releasing hormone and its agonistsNikolina Dioufa, Andrew V Schally, Ioulia Chatzistamou, et al.
Cancer Research|November 1, 1983
Effect of retinoic acid on the growth and morphology of a prostatic adenocarcinoma cell line cloned for the retinoid inducibility of alkaline phosphataseD H Reese, B Gordon, H G Gratzner, et al.
Pageof 54

Showing results (371-380 of 540) with videos related to

Sort By:
Pageof 54
Vaccine|September 10, 2019
MenACWY-CRM conjugate vaccine booster dose given 4-6 years after priming: Results from a phase IIIb, multicenter, open label study in adolescents and adultsMary Tipton, Wendy Daly, Shelly Senders, et al.
Journal of Neuroinflammation|May 7, 2013
Microglial activation decreases retention of the protease inhibitor saquinavir: implications for HIV treatmentShannon Dallas, Michelle L Block, Deborah M Thompson, et al.
Journal of Allied Health|October 12, 2000
Facilitating factors for, barriers to, and outcomes of interdisciplinary education projects in the health sciencesI Ruebling, M A Lavin, R Banks, et al.
Neuroendocrinology|March 2, 2012
Inhibitory effects of GHRH antagonists on human GH-secreting adenoma tissueLuca Szalontay, Ronald J Benveniste, Andrew V Schally, et al.
The Journal of Biological Chemistry|October 28, 2003
NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microgliaLiya Qin, Yuxin Liu, Tongguang Wang, et al.
Investigative Urology|July 1, 1981
Flow cytometric monitoring of R 3327 rat prostate carcinomaJ M Collins, C B Bagwell, N L Block, et al.
The Prostate|October 15, 2010
LHRH antagonist Cetrorelix reduces prostate size and gene expression of proinflammatory cytokines and growth factors in a rat model of benign prostatic hyperplasiaFerenc G Rick, Andrew V Schally, Norman L Block, et al.
The Prostate|September 23, 2010
Receptors for luteinizing hormone-releasing hormone (LHRH) in benign prostatic hyperplasia (BPH) as potential molecular targets for therapy with LHRH antagonist cetrorelixBernadett Rozsa, Mehrdad Nadji, Andrew V Schally, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 13, 2010
Acceleration of wound healing by growth hormone-releasing hormone and its agonistsNikolina Dioufa, Andrew V Schally, Ioulia Chatzistamou, et al.
Cancer Research|November 1, 1983
Effect of retinoic acid on the growth and morphology of a prostatic adenocarcinoma cell line cloned for the retinoid inducibility of alkaline phosphataseD H Reese, B Gordon, H G Gratzner, et al.
Pageof 54